Eisai R&D Management Co., Ltd.;Bruce A. Littlefield
发明人:
Makoto ASANO,Bruce A. LITTLEFIELD,Junji MATSUI,Martin OLIVO,Yoichi OZAWA,Yanke YU
申请号：
US15314160
公开号：
US20170100367A1
申请日:
2015.05.27
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention features methods and kits for use in treating cancer in a patient in need thereof by administering eribulin or a pharmaceutically-acceptable salt thereof (e.g., eribulin mesylate) prior to a second agent.
